Interest in the new cancer treatments has surged, but expertise in development and delivery is lackingDecember 3, 2024Check out STAT+Sponsored By Mike Reddy for STAT STAT+ | 'Significant talent shortage' threatens the rise of radiopharmaceuticals Among many drug developers and providers seeking to deliver radiopharmaceuticals to patients, there is a lack of expertise in the burgeoning field. By Allison DeAngelis Opinion: A new moonshot initiative to fight cervical cancer in the Indo-Pacific region is missing something Over the coming years, the challenge to reaching the WHO's recommended coverage of 90% of girls may have less to do with capacity and more to do with will. By Fengting Yan, Binay Shah, and Siddhartha Yadav Private Medicare insurers are likely to benefit in Trump's new administration The Medicare Advantage program is expected to cost taxpayers and beneficiaries more than $500 billion this year. By Bob Herman More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Cancer Briefing? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2024, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments